View ValuationCresco Labs 将来の成長Future 基準チェック /06Cresco Labsは、116.3%と2.1%でそれぞれ年率116.3%で利益と収益が成長すると予測される一方、EPSはgrowで88.9%年率。主要情報116.3%収益成長率88.85%EPS成長率Pharmaceuticals 収益成長14.5%収益成長率2.1%将来の株主資本利益率n/aアナリストカバレッジGood最終更新日11 May 2026今後の成長に関する最新情報お知らせ • Aug 17Cresco Labs Inc. Provides Revenue Guidance for the Second Half of 2023Cresco Labs Inc. provided revenue guidance for the second half of 2023. For the period, the company expects total revenue to be down high single digits compared to the first half of the year.すべての更新を表示Recent updatesお知らせ • Apr 23Cresco Labs Inc. to Report Q1, 2026 Results on May 08, 2026Cresco Labs Inc. announced that they will report Q1, 2026 results Pre-Market on May 08, 2026お知らせ • Feb 23Cresco Labs Inc. to Report Q4, 2025 Results on Mar 05, 2026Cresco Labs Inc. announced that they will report Q4, 2025 results at 9:30 AM, US Eastern Standard Time on Mar 05, 2026お知らせ • Jan 30Cresco Labs Inc. has filed a Follow-on Equity Offering in the amount of CAD 140 million.Cresco Labs Inc. has filed a Follow-on Equity Offering in the amount of CAD 140 million. Security Name: Subordinate Voting Shares Security Type: Common Stock Transaction Features: At the Market Offeringお知らせ • Nov 06Cresco Labs Inc. Reports Unaudited Impairment Loss for the Third Quarter Ended September 30, 2025Cresco Labs Inc. reported unaudited impairment loss for the third quarter ended September 30, 2025. For the period, the company reported impairment loss of $2,365,000 against $2,320,000 a year ago. non-cash impairment charges of $2 million related to California assets being considered held for sale.お知らせ • Oct 22Cresco Labs Inc. to Report Q3, 2025 Results on Nov 05, 2025Cresco Labs Inc. announced that they will report Q3, 2025 results Pre-Market on Nov 05, 2025お知らせ • Jul 22Cresco Labs Inc., Annual General Meeting, Sep 16, 2025Cresco Labs Inc., Annual General Meeting, Sep 16, 2025.お知らせ • Jul 17Cresco Labs Inc. to Report Q2, 2025 Results on Aug 07, 2025Cresco Labs Inc. announced that they will report Q2, 2025 results Pre-Market on Aug 07, 2025お知らせ • May 29Cresco Labs Inc. to Report Q1, 2025 Results on May 30, 2025Cresco Labs Inc. announced that they will report Q1, 2025 results on May 30, 2025お知らせ • Apr 29Cresco Labs Inc. to Report Q1, 2025 Results on May 09, 2025Cresco Labs Inc. announced that they will report Q1, 2025 results Pre-Market on May 09, 2025お知らせ • Mar 03Cresco Labs Inc. to Report Q4, 2024 Results on Mar 12, 2025Cresco Labs Inc. announced that they will report Q4, 2024 results Pre-Market on Mar 12, 2025お知らせ • Oct 17Cresco Labs Inc. to Report Q3, 2024 Results on Nov 08, 2024Cresco Labs Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 08, 2024お知らせ • Sep 29Cresco Labs Inc. Announces Resignation of Tarik Brooks as Board of DirectorsCresco Labs Inc. announced that Tarik Brooks has resigned from the Company's Board of Directors to devote his time to other interests.お知らせ • Sep 12Cresco Labs Inc. Announces CFO ChangesCresco Labs Inc. announced that Dennis Olis, Chief Financial Officer, will retire from Cresco Labs after a planned transition to Sharon Schuler, an experienced financial and strategy executive. Schuler recently joined Cresco Labs while preparing to take the role of Chief Financial Officer upon Olis's departure. Schuler brings an extensive corporate finance background in publicly traded wholesalers and retailers, most recently as an executive leadership team member at BJ's Wholesale Club, a membership warehouse club spanning 244 clubs and 178 gas stations, across 20 states with $20 billion in annual revenue. Olis has served as Cresco Labs CFO since July 2020. During his tenure, Cresco Labs grew from $125 million in annual revenue to more than $735 million1 today. The Company also saw significant profitability improvements with Adjusted EBITDA margin improving by 2,900 basis points and annual operating cashflow improving by over $100 million annually 2. He successfully prepared the Company for future U.S. listings through conversion to US GAAP and SOX compliance readiness. For the last three years, Schuler was responsible for planning and analysis of BJ's Wholesale Club's short and long-term financial outlook. Prior to that, she spent over 20 years in senior financial management roles for large public and private national retailers including The TJX Companies, Clarks America, and Caleres. Schuler holds an MBA in Integrated Management and a bachelor's in economics from Michigan State University.お知らせ • Jul 23Cresco Labs Inc. to Report Q2, 2024 Results on Aug 08, 2024Cresco Labs Inc. announced that they will report Q2, 2024 results Pre-Market on Aug 08, 2024お知らせ • May 17Cresco Labs Inc. (CNSX:CL) acquired Two medical dispensaries in Pennsylvania of Keystone Integrated Care, LLC for $9.8 million.Cresco Labs Inc. (CNSX:CL) acquired Two medical dispensaries in Pennsylvania of Keystone Integrated Care, LLC for $9.8 million on April 24, 2024. Consideration consists of a mix of initial cash consideration, deferred consideration and equity. As part of the acquisition, the Cresco Labs Inc. acquired two operating dispensaries in Pennsylvania, as well as the rights to open a new store under a third license in the future. Cresco Labs Inc. (CNSX:CL) completed the acquisition of Two medical dispensaries in Pennsylvania of Keystone Integrated Care, LLC on April 24, 2024.お知らせ • May 01Cresco Labs Inc. to Report Q1, 2024 Results on May 15, 2024Cresco Labs Inc. announced that they will report Q1, 2024 results Pre-Market on May 15, 2024お知らせ • Apr 11Cresco Labs Inc., Annual General Meeting, Jun 10, 2024Cresco Labs Inc., Annual General Meeting, Jun 10, 2024.お知らせ • Feb 28Cresco Labs Inc. to Report Q4, 2023 Results on Mar 13, 2024Cresco Labs Inc. announced that they will report Q4, 2023 results Pre-Market on Mar 13, 2024お知らせ • Feb 01Cresco Labs Inc. Promotes Greg Butler to the Position of PresidentCresco Labs Inc. announce the promotion of Greg Butler to the position of President. In this role, Butler will oversee all aspects of Cresco Labs' operations, including production, retail operations, marketing and sales, corporate planning, and investor relations. Butler joined Cresco Labs in 2020 as Chief Commercial Officer and has advised the company since 2018. He has been instrumental in innovating and professionalizing all aspects of Cresco Labs' business including strategic planning, wholesale operations, and retail expansion. Prior to Cresco Labs, Butler had over two decades of experience leading large iconic and insurgent brands for both large Fortune 500 and smaller privately owned businesses.お知らせ • Nov 02Cresco Labs Inc. to Report Q3, 2023 Results on Nov 15, 2023Cresco Labs Inc. announced that they will report Q3, 2023 results Pre-Market on Nov 15, 2023お知らせ • Oct 20Cresco Labs Inc. completed the acquisition of Sole Licensed Arizona Operation of Cresco Labs Inc.Cresco Labs Inc. entered into a definitive agreement to acquire Sole Licensed Arizona Operation of Cresco Labs Inc. for $6.5 million on September 13, 2023. The transaction was closed following approval by the Arizona Department of Health Services. SSC Advisors acted as financial advisor to Cresco Labs Cresco Labs Inc. completed the acquisition of Sole Licensed Arizona Operation of Cresco Labs Inc. on October 17, 2023.お知らせ • Aug 17Cresco Labs Inc. Provides Revenue Guidance for the Second Half of 2023Cresco Labs Inc. provided revenue guidance for the second half of 2023. For the period, the company expects total revenue to be down high single digits compared to the first half of the year.お知らせ • Aug 03Cresco Labs Inc. to Report Q2, 2023 Results on Aug 16, 2023Cresco Labs Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 16, 2023お知らせ • May 13Cresco Labs Inc. to Report Q1, 2023 Results on May 24, 2023Cresco Labs Inc. announced that they will report Q1, 2023 results Pre-Market on May 24, 2023お知らせ • Jan 24Cresco Labs Inc. has completed a Follow-on Equity Offering in the amount of CAD 158.047776 million.Cresco Labs Inc. has completed a Follow-on Equity Offering in the amount of CAD 158.047776 million. Security Name: Subordinate Voting Shares Security Type: Common Stock Securities Offered: 6,558,983 Price\Range: CAD 16 Discount Per Security: CAD 0.64 Security Name: Subordinate Voting Shares Security Type: Common Stock Securities Offered: 3,319,003 Price\Range: CAD 16 Transaction Features: Subsequent Direct Listingお知らせ • Jan 20Cresco Labs Announces Executive ChangesCresco Labs announced the hiring of Ty Gent as the company’s new Chief Operating Officer. As COO, Gent will be responsible for operational consistency and efficiency across markets and implementation of structural enhancements to facilitate scaling. Gent joins Cresco with more than 35 years of CPG and supply chain leadership experience. Most recently, he was the Chief Supply Chain Officer at US Foods, where he developed and implemented a new supply chain strategy, optimized its large-scale transportation network, launched field-based continuous improvement processes, and upgraded key systems technologies and planning capabilities. Concurrent with Ty Gent's hiring, David Ellis will move from COO to Regional President of Operations for Emerging Markets (Massachusetts, New York, Pennsylvania, Ohio and Maryland). As part of the initial Cresco Labs team, Ellis has been crucial in laying the foundation for the Company’s end-to-end operational model and leading the growth of Illinois, Pennsylvania and California. He will be responsible for repeating that successful playbook in Cresco’s emerging markets.お知らせ • Dec 11Cresco Labs Debuts Deliciously DosedTM Chocolates from its Mindy's Chef Led Artisanal Edibles Brand for the Illinois Recreational Cannabis MarketCresco Labs announced the relaunch and availability of its cannabis-infused Chocolates line from its Mindy's Chef Led Artisanal Edibles brand in dispensaries across Illinois. Previously introduced to the state's medical market in 2016, the line is now available for the first time to recreational customers. Illinois total adult use cannabis sales topped $75 million for the second consecutive month in November. The Chocolates line features three consistently dosed chocolate bars—Milk Chocolate & Peanut Brittle, Caramelized Chocolate Marshmallow Graham and Dark Chocolate Almond Toffee. In addition, for the 2020 holiday season the brand has launched a limited-time only flavor, Dark Chocolate Peppermint Bark. Mindy Segal is Illinois' original cannabis chef and the creative force behind her namesake line of artisanal edibles. A big difference between Mindy's Chef Led Artisanal Edibles and other edible products in the market is their decadently delicious taste, featuring iconic flavor combinations and distinctive, premium ingredients. In addition, each product is precisely dosed to provide cannabis consumers with confidence to experiment with different flavors and textures. With a reputation as a renowned pastry chef and restaurant owner, Segal has taken her unmatched attention to detail and quality to the production of cannabis-infused Chocolates. Additional details on the newly available Chocolates line: Milk Chocolate & Peanut Brittle – A blend of two milk chocolates, each with a distinct flavor note, accented with smooth peanut butter and crunchy peanut brittle. 100 mg THC bar with 10 breakable, 10 mg pieces. Caramelized Chocolate Marshmallow Graham – Caramelized white chocolate nestled with crunchy graham crackers and mini marshmallows. 100 mg 1:1 CBD/THC bar with 10 breakable, 10 mg pieces. Dark Chocolate Almond Toffee – Two dark chocolates and a touch of milk chocolate with smoked almonds, crunchy toffee and smooth caramel. 100 mg THC bar with 10 breakable, 10 mg pieces. Dark Chocolate Peppermint Bark – A limited-time only offering available for the 2020 holiday season while supplies last, delivers a blend of rich, luscious dark milk chocolate with smooth white chocolate ganache drizzle, topped with crushed peppermints. 100 mg THC bar with 10 breakable, 10 mg pieces. In Illinois, the Mindy's Chef Led Artisanal Edibles suite of products includes 2 mg and 5 mg Gummies available in six flavors and now Chocolates. The brand plans to expand its offerings to include Taffy soon. Chocolates from Mindy's Chef Led Artisanal Edibles are the latest product offerings to enter Cresco Labs' Illinois market this year, following the recent launch and availability of Wonder Wellness Co. and Wonder Minis. Cresco Labs' House of Brands is available in the state for medical patients and customers, and products include the following: Cresco premium flower, pre-rolled joints, live resin concentrates and liquid live resin vape cartridges; Mindy's Chef Led Artisanal Edibles gummies and chocolates; Remedi capsules, Rick Simpson (RSO) syringes and tinctures; High Supply flower, popcorn, shake, pre-rolled joints, vape pens and live vape cartridges; Good News pre-rolled shorties, gummies and vape pens; and Wonder Wellness Co. Wonder Minis. Cresco's Mindy's Chef Led Artisanal Edibles brand is available in California, Illinois, Massachusetts and Michigan.お知らせ • Dec 02Cresco Labs Launches Eighth Cannabis Brand, Wonder Wellness CoCresco Labs announced the launch of Wonder Wellness Co. (“Wonder”), the newest brand to join its expanding portfolio of national cannabis brands. Wonder addresses the direct needs of the large segment of consumers who are accepting of cannabis but have yet to enter the category. Created to take the guesswork out of cannabis, the portfolio offers low-dose, approachable forms that are simple to use with packaging that is easy to understand, so newcomers can explore the plant and control their experience with confidence. The brand debuts in Illinois with Wonder Minis, a line of 3 mg hard sweets focused on effects-driven benefits. Wonder Minis are the first low-dose (3 mg THC or less), effects-driven hard sweets to arrive in the Illinois market. Each of the three Wonder Minis has a distinct blend of botanically derived terpene formulas, containing a total of 3 mg of cannabinoids per hard sweet. Laugh (Tangerine flavor) offers 3 mg THC; Sleep (Plum flavor) has 2 mg THC and 1 mg CBD; and Relax (Blueberry flavor) provides 1 mg THC and 2 mg CBD. Wonder Minis also represent the first dry blended and pressed product to enter Cresco’s House of Brands. The development of Wonder Minis involved new manufacturing and infusion processes to obtain low doses per serving, along with a new tablet pressing and tablet packaging lines.お知らせ • Oct 29Cresco Labs Launches 1.0 g Liquid Live Resin Vape Offering in Illinois and CaliforniaCresco Labs Inc. announced the launch of a 1.0 g Liquid Live Resin (LLR) vape cartridge in its Cresco brand portfolio. Illinois and California are the first markets to carry the Company’s newest LLR offering. Cresco Labs’ LLR is unique and differentiated from other live resin products in market because the Company uses an extraction process that flash-freezes whole flower at peak freshness, preserving premium flavor, cannabinoids and quality. Cresco Labs’ LLR extraction method starts with a single, premium cannabis strain, harvested and extracted at the peak of freshness. The cannabis oil is never separated or reconstituted, which means there are no cuts, fillers, added terpenes or non-cannabis ingredients. To deliver the best cannabis experience possible, Cresco Labs extracts the naturally occurring, full-spectrum benefits of the fresh flower, because the Company believes in preserving the integrity of the original strain. It’s pure cannabis, nothing else. In Illinois and California, the Cresco brand’s suite of LLR products includes 0.5 g and 1.0 g vape cartridges. The line also features live resin concentrates, as well as premium flower, popcorn, shake and pre-rolls. Illinois cannabis sales have increased month-over-month, with nearly $67 million in total cannabis retail sales in September. California total sales in September were $360 million. Cresco’s 1.0 g LLR vape offering is the latest product to enter Cresco Labs’ Illinois and California markets this year, following the initial debut of Mindy’s Edibles gummies; High Supply popcorn and shake, disposable vape pens and pre-rolls; and Good News pre-rolled shorties, gummy edibles and disposable vape pens.お知らせ • Oct 15Cresco Labs Launches Remedi Cannabis Brand into New YorkCresco Labs announced the launch of its Remedi brand and its Renew and Realign spray tinctures and Renew capsules in New York. In addition, Cresco has received approval for both THC only and 1:1 CBD to THC capsules, spray tinctures, syringes and vape products from its Remedi line from the New York Department of Health. Remedi is a wellness-focused brand that offers easy-to-dose, familiar forms of cannabis for adults. Its line of products includes Remedi spray tinctures, which are fast-acting, easy to use and come in two market offerings: Renew spray tincture (Sativa, 100mg THC) and Realign spray tincture (1:1, 100mg CBD:100mg THC). ?The process used to make Remedi tinctures results in a superior blend for sublingual absorption. Additionally, Remedi Renew capsules are available in Hybrid and Indica strains, both offering 100mg THC. The Remedi products recently introduced into New York have been verified as alcohol free, sugar free, gluten free and vegan. Future Remedi products sold in the market may include additional tincture and capsule options. Remedi was originally created for patients with existing medical conditions in medical cannabis states. The Remedi portfolio has evolved further to serve wellness-minded adults, including new consumers, who are interested in exploring how cannabis can become part of their personal routine. In addition to New York, select Remedi products are currently available in Illinois, Pennsylvania, Michigan, Massachusetts, Arizona and California. Remedi products will be available in New York starting with Sunnyside stores in Williamsburg, Huntington, New Hartford and Bardonia. Sunnyside offers one of the widest assortment of branded medical cannabis products of any dispensary in New York.お知らせ • Oct 14Cresco Labs Inc. to Report Q3, 2020 Results on Nov 18, 2020Cresco Labs Inc. announced that they will report Q3, 2020 results at 9:00 AM, Eastern Standard Time on Nov 18, 2020お知らせ • Sep 18Cresco Labs Bolsters Leadership Team with Three Senior PromotionsCresco Labs announced it has expanded its leadership team with the promotions of David Gacom, Melissa Wagamon and Sean McAlister to regionally focused president positions. These dynamic individuals, who bring a depth of experience in operations, marketing and sales through previous leadership roles at top CPG companies like MillerCoors, PepsiCo and The Kraft Heinz Company, will be focused on accelerating growth across the Company’s geographic footprint. As the organization continues to scale, they will be accountable for driving the Company’s strategic agenda across its nine states, delivering top-line growth and finding new ways to drive cost synergies in regional operations. In addition, these individuals will serve as the face of Cresco Labs amongst key state and local community leaders to ensure the Company is investing in what matters most to its stakeholders. David Gacom has been appointed Regional President, West Region (California and Arizona). His leadership of the California market to date resulted in 41% sequential growth in Second Quarter and Cresco Labs taking market share in the largest, most competitive cannabis market in the world. Mr. Gacom brings more than 20 years of experience in leadership roles across B2B and B2C channels to the Company, serving most recently as the Chief Commercial & Optimization Officer of Grecian Delight Foods after 13 years in various management positions at The Kraft Heinz Company. Melissa Wagamon has been promoted from VP of Brand Marketing to Regional President, Great Lakes (Illinois and Michigan). Mrs. Wagamon previously managed the development of Cresco Labs’ wholesale brands, including Cresco, Remedi, Mindy’s, High Supply, Reserve and Good News. She joined Cresco Labs from MillerCoors where she oversaw the retail and recruitment strategy for the Coors Light brand and communications strategy as Director for the Miller Lite brand. She also worked in various marketing roles at The Kraft Heinz Company and PepsiCo and started her career in territory sales with Pfizer Inc. Sean McAlister has been promoted from EVP Sales to Regional President of Sales, Emerging Markets (Massachusetts, New York, Pennsylvania, Ohio and Maryland) and National Accounts. With the Company for over four years, Mr. McAlister has led the wholesale sales organization with a proven track record of success, getting Cresco Labs’ House of Brands into over 800 dispensaries across nine states and overseeing $55M in wholesale revenue in Q2—making Cresco Labs the large wholesaler of branded products in the cannabis industry. Mr. McAlister previously led sales for global gaming technology producer and operator, Novomatic Americas. Effective immediately, Mrs. Wagamon and Mr. McAlister will be based in Illinois and Mr. Gacom will reside in California.業績と収益の成長予測OTCPK:CRLB.F - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2028676N/A3772212/31/2027677-95385612/31/2026653-4233673/31/2026641-134-437N/A12/31/2025656-1353573N/A9/30/2025673-524475N/A6/30/2025688-4688118N/A3/31/2025708-84103126N/A12/31/2024724-74109132N/A9/30/2024733-6775100N/A6/30/2024741-1725991N/A3/31/2024747-1554892N/A12/31/2023756-176159N/A9/30/2023767-339-165N/A6/30/2023786-234-2350N/A3/31/2023806-211-4425N/A12/31/2022825-212-6719N/A9/30/2022842-65-3853N/A6/30/2022848-326-6234N/A3/31/2022841-318-114-2N/A12/31/2021806-320-8314N/A9/30/2021750-360-99-3N/A6/30/2021687-73-7420N/A3/31/2021573-105-2543N/A12/31/2020463-102-97-8N/A9/30/2020345-76-149-34N/A6/30/2020231-98-186-70N/A3/31/2020168-64-185-57N/A12/31/2019124-43N/A-25N/A9/30/2019101-20N/A-29N/A6/30/201978-14N/A-20N/A3/31/201957-12N/A-16N/A12/31/201841-2N/A-10N/A9/30/2018280N/A-4N/A6/30/2018191N/A-7N/A3/31/2018131N/A-6N/A12/31/201710-3N/A-5N/A12/31/20163-8N/A-11N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: CRLB.F今後 3 年間、利益が出ない状態が続くと予測されています。収益対市場: CRLB.F今後 3 年間、利益が出ない状態が続くと予測されています。高成長収益: CRLB.F今後 3 年間、利益が出ない状態が続くと予測されています。収益対市場: CRLB.Fの収益 ( 2.1% ) US市場 ( 11.7% ) よりも低い成長が予測されています。高い収益成長: CRLB.Fの収益 ( 2.1% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: CRLB.Fの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 07:15終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Cresco Labs Inc. 7 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。13 アナリスト機関Aaron GreyAlliance Global PartnersFrederico Yokota Choucair GomesATB CormarkRussell StanleyBeacon Securities Limited10 その他のアナリストを表示
お知らせ • Aug 17Cresco Labs Inc. Provides Revenue Guidance for the Second Half of 2023Cresco Labs Inc. provided revenue guidance for the second half of 2023. For the period, the company expects total revenue to be down high single digits compared to the first half of the year.
お知らせ • Apr 23Cresco Labs Inc. to Report Q1, 2026 Results on May 08, 2026Cresco Labs Inc. announced that they will report Q1, 2026 results Pre-Market on May 08, 2026
お知らせ • Feb 23Cresco Labs Inc. to Report Q4, 2025 Results on Mar 05, 2026Cresco Labs Inc. announced that they will report Q4, 2025 results at 9:30 AM, US Eastern Standard Time on Mar 05, 2026
お知らせ • Jan 30Cresco Labs Inc. has filed a Follow-on Equity Offering in the amount of CAD 140 million.Cresco Labs Inc. has filed a Follow-on Equity Offering in the amount of CAD 140 million. Security Name: Subordinate Voting Shares Security Type: Common Stock Transaction Features: At the Market Offering
お知らせ • Nov 06Cresco Labs Inc. Reports Unaudited Impairment Loss for the Third Quarter Ended September 30, 2025Cresco Labs Inc. reported unaudited impairment loss for the third quarter ended September 30, 2025. For the period, the company reported impairment loss of $2,365,000 against $2,320,000 a year ago. non-cash impairment charges of $2 million related to California assets being considered held for sale.
お知らせ • Oct 22Cresco Labs Inc. to Report Q3, 2025 Results on Nov 05, 2025Cresco Labs Inc. announced that they will report Q3, 2025 results Pre-Market on Nov 05, 2025
お知らせ • Jul 22Cresco Labs Inc., Annual General Meeting, Sep 16, 2025Cresco Labs Inc., Annual General Meeting, Sep 16, 2025.
お知らせ • Jul 17Cresco Labs Inc. to Report Q2, 2025 Results on Aug 07, 2025Cresco Labs Inc. announced that they will report Q2, 2025 results Pre-Market on Aug 07, 2025
お知らせ • May 29Cresco Labs Inc. to Report Q1, 2025 Results on May 30, 2025Cresco Labs Inc. announced that they will report Q1, 2025 results on May 30, 2025
お知らせ • Apr 29Cresco Labs Inc. to Report Q1, 2025 Results on May 09, 2025Cresco Labs Inc. announced that they will report Q1, 2025 results Pre-Market on May 09, 2025
お知らせ • Mar 03Cresco Labs Inc. to Report Q4, 2024 Results on Mar 12, 2025Cresco Labs Inc. announced that they will report Q4, 2024 results Pre-Market on Mar 12, 2025
お知らせ • Oct 17Cresco Labs Inc. to Report Q3, 2024 Results on Nov 08, 2024Cresco Labs Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 08, 2024
お知らせ • Sep 29Cresco Labs Inc. Announces Resignation of Tarik Brooks as Board of DirectorsCresco Labs Inc. announced that Tarik Brooks has resigned from the Company's Board of Directors to devote his time to other interests.
お知らせ • Sep 12Cresco Labs Inc. Announces CFO ChangesCresco Labs Inc. announced that Dennis Olis, Chief Financial Officer, will retire from Cresco Labs after a planned transition to Sharon Schuler, an experienced financial and strategy executive. Schuler recently joined Cresco Labs while preparing to take the role of Chief Financial Officer upon Olis's departure. Schuler brings an extensive corporate finance background in publicly traded wholesalers and retailers, most recently as an executive leadership team member at BJ's Wholesale Club, a membership warehouse club spanning 244 clubs and 178 gas stations, across 20 states with $20 billion in annual revenue. Olis has served as Cresco Labs CFO since July 2020. During his tenure, Cresco Labs grew from $125 million in annual revenue to more than $735 million1 today. The Company also saw significant profitability improvements with Adjusted EBITDA margin improving by 2,900 basis points and annual operating cashflow improving by over $100 million annually 2. He successfully prepared the Company for future U.S. listings through conversion to US GAAP and SOX compliance readiness. For the last three years, Schuler was responsible for planning and analysis of BJ's Wholesale Club's short and long-term financial outlook. Prior to that, she spent over 20 years in senior financial management roles for large public and private national retailers including The TJX Companies, Clarks America, and Caleres. Schuler holds an MBA in Integrated Management and a bachelor's in economics from Michigan State University.
お知らせ • Jul 23Cresco Labs Inc. to Report Q2, 2024 Results on Aug 08, 2024Cresco Labs Inc. announced that they will report Q2, 2024 results Pre-Market on Aug 08, 2024
お知らせ • May 17Cresco Labs Inc. (CNSX:CL) acquired Two medical dispensaries in Pennsylvania of Keystone Integrated Care, LLC for $9.8 million.Cresco Labs Inc. (CNSX:CL) acquired Two medical dispensaries in Pennsylvania of Keystone Integrated Care, LLC for $9.8 million on April 24, 2024. Consideration consists of a mix of initial cash consideration, deferred consideration and equity. As part of the acquisition, the Cresco Labs Inc. acquired two operating dispensaries in Pennsylvania, as well as the rights to open a new store under a third license in the future. Cresco Labs Inc. (CNSX:CL) completed the acquisition of Two medical dispensaries in Pennsylvania of Keystone Integrated Care, LLC on April 24, 2024.
お知らせ • May 01Cresco Labs Inc. to Report Q1, 2024 Results on May 15, 2024Cresco Labs Inc. announced that they will report Q1, 2024 results Pre-Market on May 15, 2024
お知らせ • Apr 11Cresco Labs Inc., Annual General Meeting, Jun 10, 2024Cresco Labs Inc., Annual General Meeting, Jun 10, 2024.
お知らせ • Feb 28Cresco Labs Inc. to Report Q4, 2023 Results on Mar 13, 2024Cresco Labs Inc. announced that they will report Q4, 2023 results Pre-Market on Mar 13, 2024
お知らせ • Feb 01Cresco Labs Inc. Promotes Greg Butler to the Position of PresidentCresco Labs Inc. announce the promotion of Greg Butler to the position of President. In this role, Butler will oversee all aspects of Cresco Labs' operations, including production, retail operations, marketing and sales, corporate planning, and investor relations. Butler joined Cresco Labs in 2020 as Chief Commercial Officer and has advised the company since 2018. He has been instrumental in innovating and professionalizing all aspects of Cresco Labs' business including strategic planning, wholesale operations, and retail expansion. Prior to Cresco Labs, Butler had over two decades of experience leading large iconic and insurgent brands for both large Fortune 500 and smaller privately owned businesses.
お知らせ • Nov 02Cresco Labs Inc. to Report Q3, 2023 Results on Nov 15, 2023Cresco Labs Inc. announced that they will report Q3, 2023 results Pre-Market on Nov 15, 2023
お知らせ • Oct 20Cresco Labs Inc. completed the acquisition of Sole Licensed Arizona Operation of Cresco Labs Inc.Cresco Labs Inc. entered into a definitive agreement to acquire Sole Licensed Arizona Operation of Cresco Labs Inc. for $6.5 million on September 13, 2023. The transaction was closed following approval by the Arizona Department of Health Services. SSC Advisors acted as financial advisor to Cresco Labs Cresco Labs Inc. completed the acquisition of Sole Licensed Arizona Operation of Cresco Labs Inc. on October 17, 2023.
お知らせ • Aug 17Cresco Labs Inc. Provides Revenue Guidance for the Second Half of 2023Cresco Labs Inc. provided revenue guidance for the second half of 2023. For the period, the company expects total revenue to be down high single digits compared to the first half of the year.
お知らせ • Aug 03Cresco Labs Inc. to Report Q2, 2023 Results on Aug 16, 2023Cresco Labs Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 16, 2023
お知らせ • May 13Cresco Labs Inc. to Report Q1, 2023 Results on May 24, 2023Cresco Labs Inc. announced that they will report Q1, 2023 results Pre-Market on May 24, 2023
お知らせ • Jan 24Cresco Labs Inc. has completed a Follow-on Equity Offering in the amount of CAD 158.047776 million.Cresco Labs Inc. has completed a Follow-on Equity Offering in the amount of CAD 158.047776 million. Security Name: Subordinate Voting Shares Security Type: Common Stock Securities Offered: 6,558,983 Price\Range: CAD 16 Discount Per Security: CAD 0.64 Security Name: Subordinate Voting Shares Security Type: Common Stock Securities Offered: 3,319,003 Price\Range: CAD 16 Transaction Features: Subsequent Direct Listing
お知らせ • Jan 20Cresco Labs Announces Executive ChangesCresco Labs announced the hiring of Ty Gent as the company’s new Chief Operating Officer. As COO, Gent will be responsible for operational consistency and efficiency across markets and implementation of structural enhancements to facilitate scaling. Gent joins Cresco with more than 35 years of CPG and supply chain leadership experience. Most recently, he was the Chief Supply Chain Officer at US Foods, where he developed and implemented a new supply chain strategy, optimized its large-scale transportation network, launched field-based continuous improvement processes, and upgraded key systems technologies and planning capabilities. Concurrent with Ty Gent's hiring, David Ellis will move from COO to Regional President of Operations for Emerging Markets (Massachusetts, New York, Pennsylvania, Ohio and Maryland). As part of the initial Cresco Labs team, Ellis has been crucial in laying the foundation for the Company’s end-to-end operational model and leading the growth of Illinois, Pennsylvania and California. He will be responsible for repeating that successful playbook in Cresco’s emerging markets.
お知らせ • Dec 11Cresco Labs Debuts Deliciously DosedTM Chocolates from its Mindy's Chef Led Artisanal Edibles Brand for the Illinois Recreational Cannabis MarketCresco Labs announced the relaunch and availability of its cannabis-infused Chocolates line from its Mindy's Chef Led Artisanal Edibles brand in dispensaries across Illinois. Previously introduced to the state's medical market in 2016, the line is now available for the first time to recreational customers. Illinois total adult use cannabis sales topped $75 million for the second consecutive month in November. The Chocolates line features three consistently dosed chocolate bars—Milk Chocolate & Peanut Brittle, Caramelized Chocolate Marshmallow Graham and Dark Chocolate Almond Toffee. In addition, for the 2020 holiday season the brand has launched a limited-time only flavor, Dark Chocolate Peppermint Bark. Mindy Segal is Illinois' original cannabis chef and the creative force behind her namesake line of artisanal edibles. A big difference between Mindy's Chef Led Artisanal Edibles and other edible products in the market is their decadently delicious taste, featuring iconic flavor combinations and distinctive, premium ingredients. In addition, each product is precisely dosed to provide cannabis consumers with confidence to experiment with different flavors and textures. With a reputation as a renowned pastry chef and restaurant owner, Segal has taken her unmatched attention to detail and quality to the production of cannabis-infused Chocolates. Additional details on the newly available Chocolates line: Milk Chocolate & Peanut Brittle – A blend of two milk chocolates, each with a distinct flavor note, accented with smooth peanut butter and crunchy peanut brittle. 100 mg THC bar with 10 breakable, 10 mg pieces. Caramelized Chocolate Marshmallow Graham – Caramelized white chocolate nestled with crunchy graham crackers and mini marshmallows. 100 mg 1:1 CBD/THC bar with 10 breakable, 10 mg pieces. Dark Chocolate Almond Toffee – Two dark chocolates and a touch of milk chocolate with smoked almonds, crunchy toffee and smooth caramel. 100 mg THC bar with 10 breakable, 10 mg pieces. Dark Chocolate Peppermint Bark – A limited-time only offering available for the 2020 holiday season while supplies last, delivers a blend of rich, luscious dark milk chocolate with smooth white chocolate ganache drizzle, topped with crushed peppermints. 100 mg THC bar with 10 breakable, 10 mg pieces. In Illinois, the Mindy's Chef Led Artisanal Edibles suite of products includes 2 mg and 5 mg Gummies available in six flavors and now Chocolates. The brand plans to expand its offerings to include Taffy soon. Chocolates from Mindy's Chef Led Artisanal Edibles are the latest product offerings to enter Cresco Labs' Illinois market this year, following the recent launch and availability of Wonder Wellness Co. and Wonder Minis. Cresco Labs' House of Brands is available in the state for medical patients and customers, and products include the following: Cresco premium flower, pre-rolled joints, live resin concentrates and liquid live resin vape cartridges; Mindy's Chef Led Artisanal Edibles gummies and chocolates; Remedi capsules, Rick Simpson (RSO) syringes and tinctures; High Supply flower, popcorn, shake, pre-rolled joints, vape pens and live vape cartridges; Good News pre-rolled shorties, gummies and vape pens; and Wonder Wellness Co. Wonder Minis. Cresco's Mindy's Chef Led Artisanal Edibles brand is available in California, Illinois, Massachusetts and Michigan.
お知らせ • Dec 02Cresco Labs Launches Eighth Cannabis Brand, Wonder Wellness CoCresco Labs announced the launch of Wonder Wellness Co. (“Wonder”), the newest brand to join its expanding portfolio of national cannabis brands. Wonder addresses the direct needs of the large segment of consumers who are accepting of cannabis but have yet to enter the category. Created to take the guesswork out of cannabis, the portfolio offers low-dose, approachable forms that are simple to use with packaging that is easy to understand, so newcomers can explore the plant and control their experience with confidence. The brand debuts in Illinois with Wonder Minis, a line of 3 mg hard sweets focused on effects-driven benefits. Wonder Minis are the first low-dose (3 mg THC or less), effects-driven hard sweets to arrive in the Illinois market. Each of the three Wonder Minis has a distinct blend of botanically derived terpene formulas, containing a total of 3 mg of cannabinoids per hard sweet. Laugh (Tangerine flavor) offers 3 mg THC; Sleep (Plum flavor) has 2 mg THC and 1 mg CBD; and Relax (Blueberry flavor) provides 1 mg THC and 2 mg CBD. Wonder Minis also represent the first dry blended and pressed product to enter Cresco’s House of Brands. The development of Wonder Minis involved new manufacturing and infusion processes to obtain low doses per serving, along with a new tablet pressing and tablet packaging lines.
お知らせ • Oct 29Cresco Labs Launches 1.0 g Liquid Live Resin Vape Offering in Illinois and CaliforniaCresco Labs Inc. announced the launch of a 1.0 g Liquid Live Resin (LLR) vape cartridge in its Cresco brand portfolio. Illinois and California are the first markets to carry the Company’s newest LLR offering. Cresco Labs’ LLR is unique and differentiated from other live resin products in market because the Company uses an extraction process that flash-freezes whole flower at peak freshness, preserving premium flavor, cannabinoids and quality. Cresco Labs’ LLR extraction method starts with a single, premium cannabis strain, harvested and extracted at the peak of freshness. The cannabis oil is never separated or reconstituted, which means there are no cuts, fillers, added terpenes or non-cannabis ingredients. To deliver the best cannabis experience possible, Cresco Labs extracts the naturally occurring, full-spectrum benefits of the fresh flower, because the Company believes in preserving the integrity of the original strain. It’s pure cannabis, nothing else. In Illinois and California, the Cresco brand’s suite of LLR products includes 0.5 g and 1.0 g vape cartridges. The line also features live resin concentrates, as well as premium flower, popcorn, shake and pre-rolls. Illinois cannabis sales have increased month-over-month, with nearly $67 million in total cannabis retail sales in September. California total sales in September were $360 million. Cresco’s 1.0 g LLR vape offering is the latest product to enter Cresco Labs’ Illinois and California markets this year, following the initial debut of Mindy’s Edibles gummies; High Supply popcorn and shake, disposable vape pens and pre-rolls; and Good News pre-rolled shorties, gummy edibles and disposable vape pens.
お知らせ • Oct 15Cresco Labs Launches Remedi Cannabis Brand into New YorkCresco Labs announced the launch of its Remedi brand and its Renew and Realign spray tinctures and Renew capsules in New York. In addition, Cresco has received approval for both THC only and 1:1 CBD to THC capsules, spray tinctures, syringes and vape products from its Remedi line from the New York Department of Health. Remedi is a wellness-focused brand that offers easy-to-dose, familiar forms of cannabis for adults. Its line of products includes Remedi spray tinctures, which are fast-acting, easy to use and come in two market offerings: Renew spray tincture (Sativa, 100mg THC) and Realign spray tincture (1:1, 100mg CBD:100mg THC). ?The process used to make Remedi tinctures results in a superior blend for sublingual absorption. Additionally, Remedi Renew capsules are available in Hybrid and Indica strains, both offering 100mg THC. The Remedi products recently introduced into New York have been verified as alcohol free, sugar free, gluten free and vegan. Future Remedi products sold in the market may include additional tincture and capsule options. Remedi was originally created for patients with existing medical conditions in medical cannabis states. The Remedi portfolio has evolved further to serve wellness-minded adults, including new consumers, who are interested in exploring how cannabis can become part of their personal routine. In addition to New York, select Remedi products are currently available in Illinois, Pennsylvania, Michigan, Massachusetts, Arizona and California. Remedi products will be available in New York starting with Sunnyside stores in Williamsburg, Huntington, New Hartford and Bardonia. Sunnyside offers one of the widest assortment of branded medical cannabis products of any dispensary in New York.
お知らせ • Oct 14Cresco Labs Inc. to Report Q3, 2020 Results on Nov 18, 2020Cresco Labs Inc. announced that they will report Q3, 2020 results at 9:00 AM, Eastern Standard Time on Nov 18, 2020
お知らせ • Sep 18Cresco Labs Bolsters Leadership Team with Three Senior PromotionsCresco Labs announced it has expanded its leadership team with the promotions of David Gacom, Melissa Wagamon and Sean McAlister to regionally focused president positions. These dynamic individuals, who bring a depth of experience in operations, marketing and sales through previous leadership roles at top CPG companies like MillerCoors, PepsiCo and The Kraft Heinz Company, will be focused on accelerating growth across the Company’s geographic footprint. As the organization continues to scale, they will be accountable for driving the Company’s strategic agenda across its nine states, delivering top-line growth and finding new ways to drive cost synergies in regional operations. In addition, these individuals will serve as the face of Cresco Labs amongst key state and local community leaders to ensure the Company is investing in what matters most to its stakeholders. David Gacom has been appointed Regional President, West Region (California and Arizona). His leadership of the California market to date resulted in 41% sequential growth in Second Quarter and Cresco Labs taking market share in the largest, most competitive cannabis market in the world. Mr. Gacom brings more than 20 years of experience in leadership roles across B2B and B2C channels to the Company, serving most recently as the Chief Commercial & Optimization Officer of Grecian Delight Foods after 13 years in various management positions at The Kraft Heinz Company. Melissa Wagamon has been promoted from VP of Brand Marketing to Regional President, Great Lakes (Illinois and Michigan). Mrs. Wagamon previously managed the development of Cresco Labs’ wholesale brands, including Cresco, Remedi, Mindy’s, High Supply, Reserve and Good News. She joined Cresco Labs from MillerCoors where she oversaw the retail and recruitment strategy for the Coors Light brand and communications strategy as Director for the Miller Lite brand. She also worked in various marketing roles at The Kraft Heinz Company and PepsiCo and started her career in territory sales with Pfizer Inc. Sean McAlister has been promoted from EVP Sales to Regional President of Sales, Emerging Markets (Massachusetts, New York, Pennsylvania, Ohio and Maryland) and National Accounts. With the Company for over four years, Mr. McAlister has led the wholesale sales organization with a proven track record of success, getting Cresco Labs’ House of Brands into over 800 dispensaries across nine states and overseeing $55M in wholesale revenue in Q2—making Cresco Labs the large wholesaler of branded products in the cannabis industry. Mr. McAlister previously led sales for global gaming technology producer and operator, Novomatic Americas. Effective immediately, Mrs. Wagamon and Mr. McAlister will be based in Illinois and Mr. Gacom will reside in California.